Healthcare Value Capital Llc increased its stake in Depomed Inc (DEPO) by 600% based on its latest 2017Q3 regulatory filing with the SEC. Healthcare Value Capital Llc bought 600,000 shares as the company’s stock declined 38.37% while stock markets rallied. The hedge fund held 700,000 shares of the health care company at the end of 2017Q3, valued at $4.05 million, up from 100,000 at the end of the previous reported quarter. Healthcare Value Capital Llc who had been investing in Depomed Inc for a number of months, seems to be bullish on the $524.90M market cap company. The stock decreased 1.65% or $0.14 during the last trading session, reaching $8.33. About 488,076 shares traded. Depomed, Inc. (NASDAQ:DEPO) has declined 46.86% since January 14, 2017 and is downtrending. It has underperformed by 63.56% the S&P500.
Hexavest Inc increased its stake in Yamana Gold Inc (AUY) by 20.23% based on its latest 2017Q3 regulatory filing with the SEC. Hexavest Inc bought 2.44 million shares as the company’s stock declined 9.06% while stock markets rallied. The hedge fund held 14.49M shares of the precious metals company at the end of 2017Q3, valued at $38.36M, up from 12.05 million at the end of the previous reported quarter. Hexavest Inc who had been investing in Yamana Gold Inc for a number of months, seems to be bullish on the $3.21B market cap company. The stock increased 2.99% or $0.1 during the last trading session, reaching $3.44. About 10.78 million shares traded or 12.45% up from the average. Yamana Gold Inc. (NYSE:AUY) has declined 40.97% since January 14, 2017 and is downtrending. It has underperformed by 57.67% the S&P500.
Among 12 analysts covering Yamana Gold Inc. (NYSE:AUY), 3 have Buy rating, 1 Sell and 8 Hold. Therefore 25% are positive. Yamana Gold Inc. had 39 analyst reports since July 22, 2015 according to SRatingsIntel. TD Securities maintained the stock with “Buy” rating in Monday, October 16 report. BMO Capital Markets maintained the shares of AUY in report on Monday, December 18 with “Hold” rating. The stock of Yamana Gold Inc. (NYSE:AUY) has “Mkt Perform” rating given on Monday, January 18 by Raymond James. BMO Capital Markets upgraded the shares of AUY in report on Thursday, May 12 to “Outperform” rating. As per Thursday, October 26, the company rating was maintained by BMO Capital Markets. The firm has “Hold” rating by BMO Capital Markets given on Monday, September 25. RBC Capital Markets maintained the shares of AUY in report on Tuesday, October 17 with “Buy” rating. The rating was initiated by JP Morgan with “Overweight” on Friday, December 11. The rating was maintained by BMO Capital Markets with “Hold” on Tuesday, June 20. The rating was maintained by TD Securities with “Buy” on Friday, May 5.
Hexavest Inc, which manages about $16.29B and $8.16B US Long portfolio, decreased its stake in Wipro Ltd (NYSE:WIT) by 853,489 shares to 384,645 shares, valued at $2.19M in 2017Q3, according to the filing. It also reduced its holding in Rogers Communication Co (NYSE:RCI) by 209,848 shares in the quarter, leaving it with 286,186 shares, and cut its stake in Newmont Mining Corp (NYSE:NEM).
Investors sentiment increased to 1.21 in 2017 Q3. Its up 0.34, from 0.87 in 2017Q2. It is positive, as 23 investors sold DEPO shares while 40 reduced holdings. 24 funds opened positions while 52 raised stakes. 56.42 million shares or 3.13% more from 54.71 million shares in 2017Q2 were reported. Public Employees Retirement Association Of Colorado invested in 0% or 15,957 shares. Swiss Bankshares reported 99,700 shares stake. 1.29M are held by Millennium Ltd Liability. Hbk Investments LP holds 0% in Depomed, Inc. (NASDAQ:DEPO) or 108,477 shares. Arizona State Retirement System holds 32,621 shares or 0% of its portfolio. 42,521 were reported by Metropolitan Life New York. Japan-based Tokio Marine Asset Mngmt has invested 0.14% in Depomed, Inc. (NASDAQ:DEPO). California-based Schwab Charles Invest Mngmt Inc has invested 0% in Depomed, Inc. (NASDAQ:DEPO). Alps Inc invested 0% in Depomed, Inc. (NASDAQ:DEPO). Moreover, State Street has 0% invested in Depomed, Inc. (NASDAQ:DEPO) for 2.29M shares. Tower Research Capital (Trc) holds 12,351 shares. Principal Financial Grp, Iowa-based fund reported 486,788 shares. Goldman Sachs Grp has invested 0% in Depomed, Inc. (NASDAQ:DEPO). 49,606 were accumulated by Levin Strategies Ltd Partnership. Vanguard Gru invested 0% of its portfolio in Depomed, Inc. (NASDAQ:DEPO).
Since December 14, 2017, it had 1 insider purchase, and 0 sales for $612,000 activity.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.